Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement

Abstract

The results demonstrated that SNMSD strategy could serve as a promising way to enhance EDR oral BA and NEF could be a potential candidate for the treatment of diseases in which oxidative stress plays a key role in their pathogenesis.